Setem J, Pinheiro A P, Motta V A, Morato S, Cruz A P
Laboratório de Psicobiologia, FFCLRP e Núcleo de Neurociências e Comportamento, Universidade de São Paulo, Ribeirão Preto, Brazil.
Pharmacol Biochem Behav. 1999 Mar;62(3):515-21. doi: 10.1016/s0091-3057(98)00193-2.
The present study investigated the behavioral effects of five 5-HT agonists and antagonists in the rat elevated-plus-maze using conventional and ethologically derived measures. An anxiolytic effect of the 5-HT1A agonist ipsapirone (0.25, 0.75, and 2.25 mg/kg) was detected by risk-assessment and scanning but not by percentage of open-arm entries and time spent on open arms. Anxiogenic effects of the 5-HT2C agonist TFMPP (0.1, 0.2, and 0.4 mg/kg) and 5-HT2A antagonist SR 46349B (1, 3, and 10 mg/kg) were detected by percentage of open-arm entries, time spent on open arms, scanning, end exploring, but not by risk assessment. Finally, the effects of the 5-HT3 antagonist BRL 46470 A (0.001, 0.01, and 0.1 mg/kg) and 5-HT(2A/C) antagonist RP 62203 (0.25, 1, and 4 mg/kg) were scarce in both conventional and ethologically derived measures. These results are indicative that ethological measures may sometimes be more sensitive than the standard ones, and should be used together with them when assessing serotonergic or any other novel drugs in the elevated plus-maze.
本研究采用传统及行为学衍生指标,探究了五种5-羟色胺(5-HT)激动剂和拮抗剂对大鼠高架十字迷宫行为的影响。通过风险评估和探究行为检测到5-HT1A激动剂 ipsapirone(0.25、0.75和2.25毫克/千克)具有抗焦虑作用,但通过进入开放臂的百分比和在开放臂上停留的时间未检测到该作用。通过进入开放臂的百分比、在开放臂上停留的时间、探究行为和终点探索行为检测到5-HT2C激动剂TFMPP(0.1、0.2和0.4毫克/千克)和5-HT2A拮抗剂SR 46349B(1、3和10毫克/千克)具有致焦虑作用,但通过风险评估未检测到该作用。最后,在传统及行为学衍生指标中均未发现5-HT3拮抗剂BRL 46470 A(0.001、0.01和0.1毫克/千克)和5-HT(2A/C)拮抗剂RP 62203(0.25、1和4毫克/千克)有明显作用。这些结果表明,行为学指标有时可能比标准指标更敏感,在高架十字迷宫中评估血清素能药物或任何其他新型药物时,应将其与标准指标一起使用。